...
Sunday . 11 January . 2026
Breaking Update

Israeli Medical Device Firm Advances Prostate Treatment Toward U.S. FDA Approval

Israeli medical device firm Butterfly Medical's BPH treatment, Butterfly Prostatic Retraction Device, completed a 244-patient trial, paving the way for U.S.

Pesach Benson Business

Jerusalem, 11 January, 2026 (TPS-IL) — Israeli medical device company Butterfly Medical announced the successful completion of its pivotal international trial for the Butterfly Prostatic Retraction Device, a minimally invasive treatment for benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland.

The 244-patient study, conducted in Boston and Yokneam, Israel, confirmed the device’s safety and efficacy in restoring urinary flow without surgery. The CE Mark-approved implant is now positioned for a U.S. FDA pre-market approval application. Butterfly Medical’s device offers an alternative for men dissatisfied with medication but seeking to avoid invasive surgery, potentially reshaping global BPH care.

author avatar
Pesach Benson
Live Breaking Updates

Breaking News Coverage

Real-time breaking news coverage from Israel and the Middle East. Stay informed with the latest developments as they happen.

Sunday, 11 January 2026 Updated continuously
Politics 27 minutes ago New

Haifa Metro: Millions for expansion approved

Israel's Metronit project in Haifa and Tirat Carmel receives NIS 62 million budget boost for expansion, part of a NIS 700 million total investment.

Politics 27 minutes ago New

Haifa Metro: Millions for expansion

Israel's Ministry of Transportation and Finance approve NIS 62 million for Haifa's Metronit expansion, part of a NIS 700 million project to create fast public.

Politics 43 minutes ago New

East Jerusalem men indicted for $28M fraud

Five East Jerusalem men indicted for orchestrating a $28 million tax fraud scheme, distributing fictitious invoices and unlawfully deducting input tax in.

Business 2 hours ago New

Israeli AI Firm CytoReason Expands Drug Discovery Partnership With France’s Sanofi

Israeli AI firm CytoReason expands drug discovery partnership with Sanofi in a new multi-year agreement valued up to $16 million, marking its fifth commercial.

Security 2 hours ago New

Europe Certifies Israeli AI Screening System in First for Airport Security

Israel's SeeTrue AI achieves a major milestone as Europe certifies its AI screening system for prohibited items, boosting airport security and efficiency.

Business 2 hours ago New

Tel Aviv-Based SuperCom Secures Second Texas Electronic Monitoring Deal

Tel Aviv-based SuperCom secures its second Texas electronic monitoring contract, deploying GPS tracking and a supervision platform for a juvenile probation.

Israel Society 4 hours ago New

Israeli Soldier Wounded by Terror Gunfire

An Israeli soldier was moderately wounded by gunfire during IDF operations in Shechem (Nablus) on January 11, 2026. Forces are pursuing the terrorist.

Crime 3 days ago

President of Israel Holds Emergency Conference on Crime in Negev Arab Communities

Israeli President Isaac Herzog convenes Negev leaders for an emergency conference addressing the alarming rise in crime and violence, emphasizing the urgent.

Israel Society 3 days ago

Programs in Artificial Intelligence Training Being Offered to Israeli Reservists

Israel launches AI leadership training for 750 reservists, aiming to bridge wartime knowledge gaps and enhance high-tech industry innovation and productivity.

Disasters 3 days ago

Israel Allocates Millions for Climate Change Preparedness in Local Arab Areas

Israel allocates 16.7 million Shekels ($5.2M) for climate change preparedness in 11 Arab local authorities, including Rahat and Umm el-Fahm, to combat heat.